Sun Pharmaceutical Industries Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Sun Pharmaceutical Industries Limited Company Profile :

Sun Pharmaceutical Industries Limited (Sun Pharma) is an Indian multinational pharmaceutical company. The company manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.

The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, and controlled substances.


Sun Pharma ResultsBSE Code : 524715
NSE Symbol : SUNPHARMA
ISIN No. : INE044A01036
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Sun Pharma or you are an stock market analyst then i am sure you might for Quarterly Results of Sun Pharma.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Sun Pharma. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Sun Pharma.

Sun Pharma Q1 Results 2016-17 :

Sun Pharma will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Sun Pharma will announce its Q2 FY 2016-17 Results in the month of October 2016.

Sun Pharma will announce its Q3 FY 2016-17 Results in the month of January 2017.

Sun Pharma will announce its Q4 FY 2016-17 Results in the month of April 2017.

Sun Pharma will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Sun Pharma Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 7614.46 28269.71
Other Income  217.24 459.24
Total Income  7831.70
Expenditure  -7904.99 -20801.61
Interest  -530.64 -476.89
Depreciation  -463.98 -1013.52
PBT  -1067.91 6765.28
Tax  -5.45 -934.90
Net Profit  -1073.36 5830.38
Equity  240.66 240.66
EPS  -4.50 19.60

Note : If you like this information about Sun Pharma Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.